Key points are not available for this paper at this time.
To understand people with advanced Parkinson's Disease (aPD) experience, satisfaction, ease of use, and convenience with the foslevodopa/foscarbidopa (LDp/CDp) delivery system.
Soileau et al. (Tue,) studied this question.